A major 110-kDa phosphoprotein in rat liver and hepatoma (P 110) was identified in nuclear 0.2 M HC1 extracts from rat lymph node cells. Stimulation with concanavalin A altered both the amount of P 110 and, more strikingly, its in vivo phosphorylation in a typical biphasic manner with an initial maximum after 10 -14 h. RNA synthesis showed a similar biphasic increase. Inhibition of hnRNA synthesis (5,6 dichlorobenzimidazoleriboside), but not of DNA synthesis (hydroxyurea), depressed both the amount of P 110 and its phosphorylation markedly.There has been a considerable increase in recent years in the number of results indicating that phosphorylation of proteins is a critical step in the regulation of many different processes in cells and tissues. A specific subset of kinases is known to be activated during stimulation of cells [l] or during malignant transformation by viruses [2]. Proteins phosphorylated by these kinases are thought to regulate cell activities by mechanisms which are poorly understood at present. Even those mechanisms regulating very important cell activities, such as replication of DNA and transcription and processing of RNA, remain unclear.Phosphoproteins in different nuclear and cytoplasmic fractions from rat liver and hepatoma have been investigated in our laboratory for several years. A major in vitro phosphorylated component with a molecular mass of 110 kDa (P110) has been identified in the nuclear hnRNA protein fraction [3], in nuclear matrix [4], and in the cytoplasmic nonribosomal RNA-protein fraction [5]. We have shown that P 110 is not identical with known initiation or elongation factors in protein synthesis [3]. Its concentration in nuclei is reduced by wamanitin [6]. The possible role of the 110-kDa phosphoprotein in regulation has been investigated using rat lymph node nuclei during the first steps of cell activation. The results of this attempt to discover whether there is any correlation between amount and in vivo phosphorylation of P 110 in nuclear extracts, and RNA or DNA metabolism, are described in the following.
MATERIALS AND METHODS
Chemicals and reagentsHydroxyurea, actinomycin D and 5,6-dichlorobenzimidazoleriboside (DRB) were from Sigma (Munchen, FRG) ;